SAN FRANCISCO, May 07, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2020. First Quarter 2020 Highlights Revenue of $63.5 million for the three […]
Tag: iRhythm
iRhythm Supports Cardiac Patients During the COVID-19 Crisis, While Keeping Clinicians Safe, Through Zio Virtual Platform
Zio virtual platform reduces COVID-19 spread by monitoring higher risk patients at home New program with severely ill COVID-19 patients rolled out at three New York City hospitals within Montefiore Health System SAN FRANCISCO, April 29, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care […]
iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors
SAN FRANCISCO, April 23, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the appointment of Renee Budig to its Board of Directors effective April 23, 2020. Ms. Budig was appointed as a Class II […]
iRhythm Technologies Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Financial Outlook
SAN FRANCISCO, Feb. 27, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2019. Fourth Quarter and Full Year 2019 Highlights — […]
iRhythm Technologies Files Quarterly Report on Form 10-Q for Third Quarter 2019 and Updates Guidance for Full Year 2019
SAN FRANCISCO, Dec. 23, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced the filing of its Quarterly Report on Form 10-Q for the period ended September 30, 2019 with the Securities and Exchange Commission. […]
iRhythm Announces Participation in GUARD-AF Study Focused on Undiagnosed Atrial Fibrillation
SAN FRANCISCO, Dec. 16, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) today announced its participation in a new, randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals), sponsored by the Bristol-Myers Squibb-Pfizer Alliance (the Alliance). The study seeks to determine if earlier detection of atrial […]
iRhythm Technologies Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) announced today that it received a standard notification letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), dated November 14, 2019, stating that, as a result of not having timely filed its Quarterly Report on Form 10-Q […]
Lost Money in iRhythm Technologies, Inc.?
Gibbs Law Group Investigates Potential Securities Law Violations OAKLAND, Calif.–(BUSINESS WIRE)–iRhythm Technologies, Inc. shares fell sharply after the company filed a Notification of Late Filing with the Securities and Exchange Commission (SEC) for its Quarterly Report and revealed that it has identified errors affecting prior periods. According to iRhythm, these […]
iRhythm Technologies Announces Third Quarter 2019 Financial Results
SAN FRANCISCO, Nov. 05, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ending September 30, 2019. Third Quarter 2019 and Recent Highlights Revenue of $56.0 million for the […]
iRhythm Technologies Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today the closing of its underwritten public offering of 1,575,342 shares of its common stock at a public offering price of $73.00 […]